Todd Foley, MBA
Managing Director, MPM Capital
Todd Foley in a managing director at MPM Capital, where he focuses on biotech investments and serves on a number of MPM portfolio company boards including those of Repare Therapeutics, Chiasma (CHMA), Iconic, Rhythm (RYTM), Semma Therapeutics and Tetherex. Todd also manages MPM’s strategic investment relationship with Novartis (NVS), which MPM believes has been one of the industry’s longest standing and most prolific collaborations between venture capital investors and pharma, having committed $200 million to over a dozen companies in the biotech and healthcare IT space under a variety of creative joint equity/strategic deal structures. Prior to joining MPM, Todd’s career in the life science industry included Business Development at Genentech (Roche) and management consulting with Arthur D. Little.
Todd holds a B.S. in chemistry from MIT and an MBA from Harvard Business School.